Skip to main content

1 Result(s)

within Article Remove this filter Jacqulyne P. Robichaux Remove this filter Molecular Medicine Remove this filter

and

  1. No Access

    Article

    Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

    Although most activating mutations of epidermal growth factor receptor (EGFR)-mutant non–small cell lung cancers (NSCLCs) are sensitive to available EGFR tyrosine kinase inhibitors (TKIs), a subset with altera...

    Jacqulyne P. Robichaux, Yasir Y. Elamin, Zhi Tan, Brett W. Carter… in Nature Medicine (2018)